ONCO News | Roxom Stocks

1 BTC

- USD

Loading market data...

Mkt Cap

$2.5M

Volume

581.01K

Next Earnings

November 12th

Chart Financials Earnings News About Insider Filings

Onconetix Highlights Realbotix Partnership with Bloom Services to Launch UK Pilot Using Humanoid Robots to Combat Elderly Social IsolationOnconetix announced that Realbotix, its pending acquisition target, has partnered with Bloom Procurement Services to launch a pilot program deploying socially assistive humanoid robots in UK care settings to address loneliness among elderly residents. Realbotix has been accredited as a supplier on Bloom's public sector marketplace. The acquisition is expected to close in the second half of 2026, subject to shareholder approval and regulatory clearances.GlobeNewswire Inc. · Jul 7, 2026

Onconetix (ONCO) Stock Surges Over 23% Overnight: Why Is It Moving?Onconetix Inc. (NASDAQ:ONCO) shares surged 23.65% to $0.38 in after-hours trading on Monday, reversing an 18.26% regular session decline. The biotech company reported clinical validation progress for Proclarix, a blood test for prostate cancer detection, with new peer-reviewed publications and initiation of a U.S. validation trial with Labcorp. However, the stock has dropped 99.11% over the past 12 months and currently trades at its annual low.Benzinga · May 19, 2026

What's Going On With Onconetix Shares On Friday?Onconetix shares surged 71.74% in premarket trading on Friday following the announcement of its acquisition of Realbotix, a company specializing in AI-driven humanoid robots. The acquisition is expected to enhance Onconetix's capabilities in AI and robotics. Additionally, the company implemented a 1-for-5 reverse stock split effective March 25. Despite the positive premarket movement, the stock remains down 92.97% over the past 12 months and trades near its 52-week low.Benzinga · Mar 27, 2026

Onconetix and Ocuvex Therapeutics announce execution of definitive merger agreementOnconetix and Ocuvex Therapeutics have signed a definitive merger agreement where Onconetix will acquire Ocuvex, with Ocuvex shareholders receiving 90% of the combined company's equity. The transaction is expected to close in Q4 and aims to bring ophthalmic therapeutic assets to the public markets.Benzinga · Jul 16, 2025

Why Tellurian Shares Are Trading Higher By Around 65%; Here Are 20 Stocks Moving Premarket - BenzingaTellurian Inc. shares rose sharply after Woodside Energy announced plans to acquire the company for $900 million. Several other stocks also saw significant pre-market movement, both positive and negative.Benzinga · Jul 22, 2024

Onconetix Announces Closing of Warrant Exercise for $1.11 Million Gross Proceeds - GlobeNewswireOnconetix, Inc. announced the closing of the exercise of existing warrants and the issuance of new warrants in a private placement, raising approximately $1.11 million. The company plans to use the proceeds for working capital and general corporate purposes.GlobeNewswire Inc. · Jul 15, 2024

Onconetix Announces Appointment of Seasoned Biotech Executives Dr. Ajit Singh and Dr. Thomas Meier to Its Board of DirectorsCINCINNATI, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Onconetix, Inc., (Nasdaq: ONCO) ("Onconetix" or the “Company”), a commercial stage biotechnology company focused on developing and commercializing therapeutics, diagnostics, and services for clinicians and patients in oncology, today announced the appointment of Ajit Singh, Ph.D. and Thomas Meier, Ph.D. to its Board of Directors.GlobeNewswire Inc. · Feb 13, 2024

Why Fortinet Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving PremarketShares of Fortinet, Inc. (NASDAQ: FTNT) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued guidance. Fortinet reported quarterly earnings of 51 cents per share, which beat the analyst consensus estimate of 43 cents by 18.6%. The company reported quarterly sales of $1.42 billion, beating the analyst consensus estimate of $1.41 billion. Fortinet anticipates full-year 2024 revenue between $5.71 billion and $5.81 billion and an adjusted EPS of $1.65 to $1.70. Fortinet shares gained 9.4% to $73.80 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers MariaDB plc (NYSE: MRDB) gained 125.2% to $0.5423 in pre-market trading after jumping more than 26% on Tuesday. Psyence Biomedical Ltd. (NASDAQ: PBM) shares jumped 41.2% to $2.19 in pre-market trading after gaining around 9% on Tuesday. Griid Infrastructure Inc. (NASDAQ: GRDI) gained 27.4% to $2.70 in pre-market trading after gaining over 4% on Tuesday. Solidion Technology Inc. (NASDAQ: STI) shares gained 20.8% to $2.50 in pre-market trading after dipping over 30% on Tuesday. Zapp ...Benzinga · Feb 7, 2024

Why Intel Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day SessionShares of Intel Corporation (NASDAQ: INTC) fell sharply during Friday’s session. Intel reported upbeat results for its fourth quarter, but issued a weak forecast for the first quarter. The company is guiding for first quarter revenue to be in a range of $12.2 billion to $13.2 billion, which is shy of a Street estimate of $14.2 billion, according to data from Benzinga Pro. Intel sees first quarter earnings per share hitting 13 cents, which is below a Street estimate of 33 cents per share. Intel shares dipped 10.7% to $44.23 on Friday. Here are some other stocks moving in today's mid-day session. Gainers Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) jumped 146% to $20.76 after the company announced data from the first-in-human clinical study of CRB-701 is being presented as a poster by its development partner CSPC Pharmaceutical at ASCO GU 2024. Inspire Veterinary Partners, Inc. (NASDAQ: IVP) jumped 121% to $0.4220 after jumping over 22% on Thursday. Aclarion, Inc. (NASDAQ: ACON) shares climbed 69.7% to $3.1650. Panbela Therapeutics, Inc. (NASDAQ: PBLA) surged 32% to $4.31. Panbela Therapeutics has reached 50% enrollment in ASPIRE trial of ivospemin plus gemcitabine and nab-paclitaxel combo in first-line treatment of metastatic pancreatic cancer. Meiwu Technology Company Limited (NASDAQ: WNW) gained 26.5% to $10.55. AppFolio, Inc. (NASDAQ: APPF) gained 25.7% to $219.23 after the company reported better-than-expected fourth-quarter financial results and issued guidance. Vera Therapeutics, Inc. (NASDAQ: VERA) jumped 20.6% to $30.54. Raymond James analyst Steven Seedhouse upgraded Vera Therapeutics from Outperform to Strong Buy and raised the price target from $29 to $37. Cyngn Inc. (NASDAQ: CYN) surged 19.8% to $0.2575. Cyngn shares jumped over 17% on Thursday after the company disclosed a strategic shift to Nvidia AI computers that will transform the technology powering its fleet of DriveMod autonomous industrial ...Benzinga · Jan 26, 2024

US Stocks Mixed; Core PCE Prices Rise In DecemberU.S. stocks traded mixed this morning, following the release of PCE price inflation data. Following the market opening Friday, the Dow traded up 0.12% to 38,096.06 while the NASDAQ fell 0.19% to 15,481.44. The S&P 500 also fell, dropping, 0.05% to 4,891.94. Check This Out: Snap To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Friday Leading and Lagging Sectors Health care shares rose by 0.5% on Friday. In trading on Friday, information technology shares fell by 0.8%. Top Headline The headline PCE annual inflation rate held at 2.6% in December, matching both the previous and expected rate of 2.6%. On a monthly basis, the PCE price index rebounded with a 0.2% increase, recovering from a 0.1% decline in November and matching the predicted 0.2% rise. Equities Trading UP Inspire Veterinary Partners, Inc. (NASDAQ: IVP) shares shot up 110% to $0.4067 after jumping over 22% on Thursday. Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) got a boost, surging 112% to $17.92 after the company announced data from the first-in-human clinical study of CRB-701 is being presented ...Benzinga · Jan 26, 2024

ONCOOnconetix, Inc. Common Stock

ONCO

Pay with—

Start Trading

Available Balance0.00

Your PositionYou don't own any ONCO yet.

Related Tickers

Earnings

Mkt Cap

$2.5M

Volume

581.01K

Next Earnings

November 12th